2026-W46 · Nov 9–Nov 15 · Company · Profile · published
Cardinal Health company profile · pharmaceutical & medical products distribution · history · financial snapshot · S&P 500 rank #212 · 康德樂公司業務歷史財務與標普500地位
SNAPSHOT
| Ticker | CAH (NYSE) |
| Company | Cardinal Health, Inc. |
| GICS sector / industry | Health Care (XLV) / Health Care Providers & Services |
| S&P 500 rank (by weight) | #212 · 0.08% (Oct 30, 2026) |
| Sector rank (by market cap) | #26 in Health Care (Oct 30, 2026) |
| Share price (frozen benchmark) | $250.48 (Oct 30, 2026) |
| Headquarters | Dublin, Ohio |
| Founded | 1971 (as Cardinal Foods) |
| CEO | Jason M. Hollar (CEO) |
| Employees | about 48,000 (2025 profile) |
| Market cap | $58.00B (Oct 30, 2026) |
WHAT IT DOES
Cardinal Health is one of the three largest pharmaceutical distributors in the United States, moving branded and generic drugs from manufacturers to pharmacies, hospitals and clinics, and it also manufactures and distributes medical and surgical products. Its scale lets it negotiate purchasing terms and run a national logistics network that delivers daily.
The model is high-volume, low-margin distribution: revenue is enormous, margins are thin, and profit comes from purchasing scale, logistics efficiency and fee-based services. FY2025 revenue was $222.58B, down 1.9% from $226.83B, and net income was $1.56B.
Cardinal's fiscal year ends June 30, so its FY2025 is the year ended June 30, 2025 — not the calendar year. The following fiscal year, FY2026, reported higher revenue of $254.25B; that is a different fiscal year and is not used in this profile.
BUSINESS SEGMENTS — FY2025 NET SALES
| Segment | Revenue | Share | YoY |
|---|---|---|---|
| Pharmaceutical segment | — | — | — |
| Medical segment | — | — | — |
HISTORY
| Year | Milestone |
|---|---|
| 1971 | Founded in Columbus, Ohio, as Cardinal Foods, a food distributor |
| 1979 | Enters pharmaceutical distribution |
| 1983 | Initial public offering |
| 1990s | Grows by acquisition into one of the largest United States drug distributors |
| 2025 | FY2025 revenue reaches $222.58B for the year ended June 30, 2025 |
COMPETITIVE POSITION
FINANCIAL SNAPSHOT — FY2025
| Total revenue | $222.58B (−1.9% YoY) |
| Prior-year revenue | $226.83B |
| Net income | $1.56B |
KEY RISKS
WHY IT MATTERS FOR THE S&P 500
Cardinal is the S&P 500's drug distributor: at a 0.08% index weight and #26 in Health Care by market cap, it is the index's main exposure to pharmaceutical distribution economics.
Its volumes are a standing read on United States drug demand — prescription flows through its warehouses before they show up in pharmacy sales.
SOURCES & METHODOLOGY
| Market data | Slickcharts S&P 500 by weight (rank, weight, price — Oct 30, 2026 close) |
| Financials | Cardinal Health FY2025 Form 10-K results (fiscal year ended June 30, 2025), company profile sources |
| Sector classification | GICS (Health Care Providers & Services) via the List of S&P 500 companies (Wikipedia) |
| Library data | SPXSet logo library, compiled from company official websites, filings, or Wikipedia; as company logos are dynamic corporate information, no 100% guarantee is made for the graphics. SPXSet chart library, monthly bars, compiled from Yahoo public information. |
Source: Yahoo Finance monthly bars, split-adjusted · Data as of Sep 30, 2026 (last closed month) · SPXSet.com
FINANCIALS
公司快照
| 代碼 | CAH(NYSE) |
| 公司 | Cardinal Health, Inc. |
| GICS 板塊/行業 | 醫療保健(XLV)/醫療保健供應商與服務 |
| 標普500排名(按權重) | #212 · 0.08%(2026 年 10 月 30 日) |
| 板塊內排名(按市值) | 醫療保健第 #26(2026 年 10 月 30 日) |
| 股價(凍結基準) | $250.48(2026 年 10 月 30 日) |
| 總部 | 美國俄亥俄州都柏林 |
| 成立 | 1971 年(原名 Cardinal Foods) |
| 行政總裁 | Jason M. Hollar(行政總裁) |
| 員工 | 約 48,000(2025 年簡介) |
| 市值 | $58.00B(2026 年 10 月 30 日) |
業務概覽
康德樂是美國三大藥品分銷商之一,將品牌藥與仿製藥由廠商運往藥房、醫院與診所,並製造及分銷醫療與外科產品。其規模令其可談判採購條件,並經營每日送貨的全國物流網絡。
其模式為高銷量、低利潤分銷:收入龐大、利潤率薄,利潤來自採購規模、物流效率與收費服務。FY2025 收入為 $222.58B,同比下跌 1.9%(FY2024 為 $226.83B),淨利潤為 $1.56B。
康德樂財政年度截至 6 月 30 日,故其 FY2025 為截至 2025 年 6 月 30 日的年度,並非曆年。其後一財政年度 FY2026 收入較高,為 $254.25B;那是另一財政年度,本簡介不予採用。
業務板塊 — FY2025
| 板塊 | 收入 | 佔比 | 同比 |
|---|---|---|---|
| 藥品板塊 | — | — | — |
| 醫療板塊 | — | — | — |
歷史沿革
| 年份 | 里程碑 |
|---|---|
| 1971 | 在俄亥俄州哥倫布創立,原名 Cardinal Foods,為食品分銷商 |
| 1979 | 進入藥品分銷 |
| 1983 | 首次公開招股 |
| 1990 年代 | 透過收購成長為美國最大的藥品分銷商之一 |
| 2025 | FY2025 收入達 $222.58B,財政年度截至 2025 年 6 月 30 日 |
競爭地位
財務快照 — FY2025
| 總收入 | $222.58B(同比 −1.9%) |
| 上年度收入 | $226.83B |
| 淨利潤 | $1.56B |
主要風險
對標普500的重要性
康德樂是標普500的藥品分銷商:指數權重 0.08%、醫療保健板塊市值第 #26,是指數對藥品分銷經濟的主要敞口。
其銷量是美國藥品需求的常設讀數——處方藥流經其倉庫後,方體現於藥房銷售。
來源與方法
| 市場數據 | Slickcharts 標普500權重榜(排名、權重、價格——2026 年 10 月 30 日收盤) |
| 財務 | 康德樂 FY2025 Form 10-K 業績(財政年度截至 2025 年 6 月 30 日)、公司簡介來源 |
| 板塊分類 | GICS(醫療保健供應商與服務),據 S&P 500 公司清單(Wikipedia) |
| 圖庫數據 | SPXSet logo 庫,整理自企業官方網站、文件或維基百科;由於是企業自身動態資訊,不對圖形做百分百保證。 SPXSet 圖表庫月線,整理自 Yahoo 公開資訊。 |
來源:Yahoo Finance 月 K(經拆股調整)· 數據截至 2026 年 9 月 30 日(最後已收月份) · SPXSet.com
財報
SPXSet in-house research — market structure, options and volatility. Not investment advice.
SPXSet 站內獨立研究,聚焦 SPX 市場結構、期權與波動率;內容不構成投資建議。
Entered 2026-10-31 11:33 · updated 2026-11-14 23:07 · rev 6